Sunday, September 25, 2022
HomeLatest Pharma-News

Latest Pharma-News

Latest Pharma-News

New ARASENS data reinforce strong tolerability profile of darolutamide plus ADT and docetaxel for mHSPC

admin - 0
Latest Pharma-News

U.S. confirmed as country with circulating vaccine-derived poliovirus

admin - 0
Latest Pharma-News

WHO launches guide to safely unlock benefits of the life sciences

admin - 0
Latest Pharma-News

Novartis invests in early technical development capabilities for next-generation biotherapeutics

admin - 0
Latest Pharma-News

Imfinzi plus chemotherapy improved survival benefit in advanced biliary tract cancer

admin - 0
Latest Pharma-News

Novartis invests in early technical development capabilities for next-generation biotherapeutics

admin - 0
Latest Pharma-News

FDA Issues Safety Alert for Squamous Cell Carcinoma and Various Lymphomas in Scar Tissue around Breast Implants

admin - 0
Latest Pharma-News

Novartis Kisqali® adds one more year of survival benefit for broadest set of patients

admin - 0
Latest Pharma-News

Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference

admin - 0
Latest Pharma-News

New Dupixent data at EADV 2022 adds to body of evidence across multiple inflammatory skin diseases

admin - 0
Latest Pharma-News

Forxiga approved in China for the treatment of chronic kidney disease

admin - 0
Latest Pharma-News

Manus Bio receives additional funding to fight malaria

admin - 0
123...135Page 1 of 135
- Advertisment -

Most Read

EDITOR PICKS

POPULAR POSTS

POPULAR CATEGORY

ABOUT US

LifeProNow provides guidance and high quality contents to help job seekers to get their dream Job. All the contents are written by experienced folks and peer reviewed by experts.

Contact us: [email protected]

FOLLOW US

© LifeProNow | All Rights Reserved